Sensei Biotherapeutics is developing an innovative pipeline of first-in-class immune activating agents for a broad array of cancers including solid tumors and hematological malignancies. Our therapies benefit from a precision medicine approach that has the potential to identify patients that will benefit most from our therapies.

Biotechnology

Education

Sensei Bio

John K. Celebi

Humberto Moran

Guolin Zhang

Cassie Fielding

Adejumoke Onumajuru

Donelson Smith

Michael Biega

Kristen Dougherty

Hanspeter Waldner

Bao Le

Thomas Thisted

Edward Van Der Horst

Christopher Gerry

Erin Colgan

Corporate Governance

Research and Development

Advisory Team

Leadership Team

Legal and Compliance

Finance and Accounting

��

Teams at Sensei Bio

Corporate Governance

Research and Development

Advisory Team

Leadership Team

Legal and Compliance

Finance and Accounting

��������

Teams at Sensei Bio

Corporate Governance

Research and Development

Advisory Team

Leadership Team

Legal and Compliance

Finance and Accounting

��